资讯

Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down ...